PEDIATRICS Vol. 117 No. 6 June 2006, pp. 2040-2046 (doi:10.1542/10.1542/peds.2005-1328)
An n-of-1 Trial Service in Clinical Practice: Testing the Effectiveness of Stimulants for Attention-Deficit/Hyperactivity Disorder
a Discipline of General Practice
c School of Population Health, The University of Queensland, Herston, Queensland, Australia
b Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, Australia
OBJECTIVE. We sought to describe the clinical use of n-of-1 trials for attention-deficit/hyperactivity disorder in publicly and privately funded family and specialized pediatric practice in Australia.
METHODS. We used a within-patient randomized, double-blind, crossover comparison of stimulant (dexamphetamine or methylphenidate) versus placebo or alternative stimulant using 3 pairs of treatment periods. Trials were conducted from a central location using mail and telephone communication, with local supervision by the patients clinicians.
PATIENTS. Our study population included children with clinically diagnosed attention-deficit/hyperactivity disorder who were aged 5 to 16 years and previously stabilized on an optimal dose of stimulant. They were selected because treatment effectiveness was uncertain.
MAIN OUTCOME MEASURES. Our measures included number of patients recruited, number of doctors who used the service, geographic spread, completion rates, response rate, and postn-of-1 trial decisions.
RESULTS. Forty-five doctors across Australia requested 108 n-of-1 trials, of which 86 were completed. In 69 drug-versus-placebo comparisons, 29 children responded better to stimulant than placebo. Immediately posttrial, 19 of 25 drug-versus-placebo responders stayed on the same stimulant, and 13 of 24 nonresponders ceased or switched stimulants. In 40 of 63 for which data were available, posttrial management was consistent with the trial results. For all types of n-of-1 trials, management changed for 28 of 64 children for whom information was available.
DISCUSSION. Attention-deficit/hyperactivity disorder n-of-1 trials can be implemented successfully by mail and telephone communication. This type of trial can be valuable in clarifying treatment effect when it is uncertain, and in this series, they had a noticeable impact on short-term management.
Key Words: n-of-1 trials attention-deficit/hyperactivity disorder
Abbreviations: ADHDattention-deficit/hyperactivity disorder DSM-IVDiagnostic and Statistical Manual of Mental Disorders, Fourth Edition
Accepted Nov 15, 2005.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
J. N. Epstein, J. M. Langberg, P. K. Lichtenstein, B. A. Mainwaring, C. P. Luzader, and L. J. Stark Community-wide Intervention to Improve the Attention-Deficit/Hyperactivity Disorder Assessment and Treatment Practices of Community Physicians Pediatrics, July 1, 2008; 122(1): 19 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Epstein, D. Rabiner, D. E. Johnson, D. P. FitzGerald, A. Chrisman, A. Erkanli, K. K. Sullivan, J. S. March, P. Margolis, E. C. Norton, et al. Improving Attention-Deficit/Hyperactivity Disorder Treatment Outcomes Through Use of a Collaborative Consultation Treatment Service by Community-Based Pediatricians: A Cluster Randomized Trial Arch Pediatr Adolesc Med, September 1, 2007; 161(9): 835 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
Are n-of-1 Trials Useful in ADHD Treatment? Journal Watch Pediatrics and Adolescent Medicine, August 30, 2006; 2006(830): 1 - 1. [Full Text] |
||||







